anti rpa2 (Proteintech)
Structured Review

Anti Rpa2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 50 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication/RPA2+Antibody/pmc12885918-125-16-18
Average 93 stars, based on 50 article reviews
Images
1) Product Images from "A circulating microRNA-based diagnostic model for breast cancer, in which the miR-139-3p/RPA2 axis regulates the sensitivity to DNA-damaging agents"
Article Title: A circulating microRNA-based diagnostic model for breast cancer, in which the miR-139-3p/RPA2 axis regulates the sensitivity to DNA-damaging agents
Journal: Translational Cancer Research
doi: 10.21037/tcr-2025-1-2592
Figure Legend Snippet: MiR-139-3p targets RPA2 to enhance DNA damage sensitivity in breast cancer cells. (A) Venn diagram of the miR-139-3p target genes and DSB response genes. (B) The relative messenger RNA level of five potential targets in the miR-139-3p in MDA-MB-231 and MCF-7 cells transfected with NC or miR-139-3p mimics. (C) Western blot of RPA2 in the cells transfected with NC or miR-139-3p mimics. (D) The relative Firefly/Renilla luciferase activity in the 293T cells transfected with the luciferase vector containing wt or mut RPA2 3’UTR luciferase plasmids, and NC or miR-139-3p mimics. (E) Stable overexpression of RPA2 -3Flag in BC cells. (F,G) IR colony formation ability of the (F) MDA-MB-231 and (G) MCF-7 cells stably overexpressing RPA2 and transfected with miR-139-3p mimics and stained with crystal violet. 1× magnification. (H,I) Cisplatin sensitivity MTS assays of the (H) MDA-MB-231 and (I) MCF-7 cells in different groups. (J) Schematic of HR repair reporter assays (upper). The HR repair efficiency of the miR-139-3p overexpression group and the co-overexpression of the RPA2 group were measured by flow cytometry, with siBRCA1 as a positive control. (K) Schematic of NHEJ reporter assays (upper). The NHEJ efficiency of the miR-139-3p overexpression group and the co-overexpression of the RPA2 group were measured by flow cytometry, with si53BP1 as a positive control. (L) gH2AX foci immunostained for gH2AX (green) and counterstained with DAPI (blue) at 12 hours post-IR in the MDA-MB-231 cells. The gH2AX foci numbers were counted from a minimum of 150 cells. Scale bar: 10 μm. (M) RAD51 foci in the S phase immunostained for RAD51 (red) and counterstained with DAPI (blue) at 12 hours post-IR in the MDA-MB-231 cells. RAD51 foci numbers were counted from a minimum of 150 cells. Scale bar: 10 mm. ns, non-significant; *, P<0.05; **, P<0.01; ***, P<0.001. DAPI, 4’,6-diamidino-2-phenylindole; DSB, double-strand break; GEP, gene editing plasmid; GFP, green fluorescent protein; gH2AX, phosphorylated H2AX; HR, homologous recombination; iGFP, internal GFP reporter; IR, irradiation; mut, mutant type; NC, negative control; NHEJ, non-homologous end joining; wt, wild type; UTR, untranslated region.
Techniques Used: Transfection, Western Blot, Luciferase, Activity Assay, Plasmid Preparation, Over Expression, Stable Transfection, Staining, Flow Cytometry, Positive Control, Homologous Recombination, Irradiation, Mutagenesis, Negative Control, Non-Homologous End Joining
Figure Legend Snippet: The efficacy of the combination of miR-139-3p and cisplatin in vivo . (A) Schematic diagram of the construction and treatment of the xenograft model in the BALB/c nude mice. (B) Representative images of nude mice with xenograft tumors in each group. (C) Growth curve of xenograft tumors in nude mice from different groups. (D) IHC staining and analysis of the RPA2 protein in xenograft tumor. 20× magnification. (E) IHC staining and analysis of the Ki-67 protein in xenograft tumors. 1× magnification. *, P<0.05; **, P<0.01; ***, P<0.001. IHC, immunohistochemistry; NC, negative control; PBS, phosphate-buffered saline.
Techniques Used: In Vivo, Immunohistochemistry, Negative Control, Saline
Related Articles
other:Article Title: TTK activates ATR through RPA2 phosphorylation to promote olaparib resistance in ovarian cancer Article Snippet: Cells were lysed by RIPA (Beyotime, P0013B, China), following with centrifuging at 4 °C for 10 min, and the supernatants were collected. Immunohistochemistry:Article Title: LAP2α drives breast tumorigenesis by mitigating replication stress Article Snippet: .. The sources of antibodies against the following proteins or post-translational modifications were as follows: γH2AX (9718S, for IHC), CHK1 pS345 (2341S, for WB) and CHK1 (2360S, for WB), from Cell Signaling Technology; Article Title: LAP2α drives breast tumorigenesis by mitigating replication stress. Article Snippet: .. The sources of antibodies against the following proteins or post-translational modifications were as follows: γH2AX (9718S, for IHC), CHK1 pS345 (2341S, for WB) and CHK1 (2360S, for WB), from Cell Signaling Technology; RPA2 pS33 (A300-246A, for WB) from Bethly Lab; FLAG (F3165, for WB) from Sigma; H2AX (05-636, for WB) from Millipore; LAP2 (ab5162, for WB and human tissue IHC), Ki-67 (ab16667, for mouse tissue IHC), CldU/BrdU (ab6326, for IF), RPA2 (ab2175, for WB and IF), and RPA1 (ab176467, for WB) from Abcam; -actin ( Western Blot:Article Title: LAP2α drives breast tumorigenesis by mitigating replication stress Article Snippet: .. The sources of antibodies against the following proteins or post-translational modifications were as follows: γH2AX (9718S, for IHC), CHK1 pS345 (2341S, for WB) and CHK1 (2360S, for WB), from Cell Signaling Technology; Article Title: LAP2α drives breast tumorigenesis by mitigating replication stress. Article Snippet: .. The sources of antibodies against the following proteins or post-translational modifications were as follows: γH2AX (9718S, for IHC), CHK1 pS345 (2341S, for WB) and CHK1 (2360S, for WB), from Cell Signaling Technology; RPA2 pS33 (A300-246A, for WB) from Bethly Lab; FLAG (F3165, for WB) from Sigma; H2AX (05-636, for WB) from Millipore; LAP2 (ab5162, for WB and human tissue IHC), Ki-67 (ab16667, for mouse tissue IHC), CldU/BrdU (ab6326, for IF), RPA2 (ab2175, for WB and IF), and RPA1 (ab176467, for WB) from Abcam; -actin ( Proximity Ligation Assay:Article Title: TTK activates ATR through RPA2 phosphorylation to promote olaparib resistance in ovarian cancer Article Snippet: The LC-MS/MS analysis was performed by Applied Protein Technology (Shanghai, China). .. For PLA assay, TTK (1:100, abcam; ab11108) and RPA2( |
